Showing 1451-1460 of 2155 results for "".
- Revian: USPTO Grants Patent for Biostimulatory Approachhttps://modernaesthetics.com/news/regina-uspto-grants-patent-for-biostimulatory-approach/2472862/The United States Patent and Trademark Office (USPTO) has awarded to Revian Inc. U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the use
- Amorepacific Debuts Face Mask 3D Printing System and Flexible LED Beauty Device at CES 2020https://modernaesthetics.com/news/amorepacific-debuts-face-mask-3d-printing-system-and-flexible-led-beauty-device-at-ces-2020/2472861/Amorepacific is presenting its 3D face mask printing system (IOPE Tailored 3D Mask) and flexible LED beauty device (MakeON Flexible LED Patch) at the Consumer Electronics Show 2020 (CES 2020) in Las Vegas. Created in collaboration with the 3D printing system developer Lincsolu
- BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpthttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-allergan-and-zimmer-related-to-emsculpt/2472855/BTL Aesthetics' US affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the US Federal District Court for the District of Delaware. The lawsuit asserts
- Ortho Dermatologics Adds Key Staff to Solta Medical Business Unithttps://modernaesthetics.com/news/ortho-dermatologics-adds-key-staff-to-solta-medical-business-unit/2472854/Ortho Dermatologics is staffing up its Solta Medical Business unit. The new appointments include the following: Liz Newman, General Manager, Solta, North America Newman first joined Solta
- ISAPS: Brazil, US Remain Cosmetic Surgery Capitals of the Worldhttps://modernaesthetics.com/news/isaps-brazil-us-remain-cosmetic-surgery-capitals-of-the-world/2472850/Driven by increases in non-invasive procedures, plastic surgery across the globe is on the rise, according to the annual statistics from the International Society of Aesthetic Plastic Surgery (ISAPS), and the US and Brazil remain the cosmetic surgery capitals o
- It's A Deal: Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernaesthetics.com/news/its-a-deal-baring-private-equity-asia-agrees-to-acquire-lumenis/2472848/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. <
- Business News: Hologic to Offload Cynosure for $205Mhttps://modernaesthetics.com/news/business-news-hologic-to-offload-cynosure-for-205m/2472847/Hologic is selling Cynosure medical aesthetics business to an affiliate of investment funds managed by Clayton, Dubilier & Rice for a total purchase price of $205 million in cash, subject to certain closing adjustments. This is a tenth of the $1.6B that Hologic, a women
- Save the Date: November 20, 2019 Marks National Botox Dayhttps://modernaesthetics.com/news/save-the-date-november-20th-2019-marks-national-botox-day/2472845/November 20, 2019 will be the first-ever National Botox Cosmetic Day. Why Nov. 20? It is the busiest day on record for booking Botox cosmetic treatments in the US. And to commemorate it, Allergan is offering an exclusive deal for one day only where patients can “buy one, get
- FDA Proposes Boxed Warning on Breast Implant Riskshttps://modernaesthetics.com/news/fda-proposes-boxed-warning-on-breast-implant-risks/2472837/The FDA released a statement on its continued efforts to protect women’s health and enhance safety information available to patients considering breast implants. In draft guidance issued on Oct. 24, the FDA proposed labeling
- Merz: Cellfina for Cellulite Cleared for 5 Years of Benefithttps://modernaesthetics.com/news/merz-cellfina-for-cellulite-cleared-for-5-years-of-benefit/2472836/The FDA has cleared a new indication statement for Cellfina that shows the benefits of treatment last for five years, an increase from the previous three-year indication. Cellfina from Merz demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult femal